Regeneron Pharmaceuticals $927.89 (+109.12, 13.33%)

NASDAQ
94% success, from Analysis 108* of this Model (*Public)
Summary
LONGBUY: Best moves 18 which gains 3344.44, return on capital invested 2.8%
Date Name (*Public) Description Symbol Type Size Action
Date Value Error Logarithmic Error
Details Best Trend by Hindsight Forecast Profit or Loss
Date (*Public) Symbol Strategy Data Origin Slope Sigma Cor % Moves Sigma Moves Gain % Periods Action
Date UTC Location Action Description Object Severity User Action